Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Retained Earnings (2016)

Lixte Biotechnology Holdings' Retained Earnings history spans 7 years, with the latest figure at -$20.2 million for Q3 2016.

  • For Q3 2016, Retained Earnings fell 12.44% year-over-year to -$20.2 million; the TTM value through Sep 2016 reached -$20.2 million, down 12.44%, while the annual FY2015 figure was -$18.6 million, N/A changed from the prior year.
  • Retained Earnings reached -$20.2 million in Q3 2016 per LIXT's latest filing, down from -$19.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $13.9 million in Q1 2014 to a low of -$20.2 million in Q3 2016.
  • Average Retained Earnings over 5 years is -$4.5 million, with a median of -$13.8 million recorded in 2013.
  • Peak YoY movement for Retained Earnings: soared 54.23% in 2012, then tumbled 220.14% in 2015.
  • A 5-year view of Retained Earnings shows it stood at $11.6 million in 2012, then tumbled by 211.88% to -$13.0 million in 2013, then fell by 16.77% to -$15.1 million in 2014, then decreased by 22.8% to -$18.6 million in 2015, then fell by 8.71% to -$20.2 million in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Retained Earnings are -$20.2 million (Q3 2016), -$19.5 million (Q2 2016), and -$19.0 million (Q1 2016).